有氧运动联合运动复杂性作为抑郁症药物治疗附加干预的随机对照试验方案
研究旨在比较两种运动方案对抑郁评分、认知功能、海马体积等的影响。
要点
- 连续有氧运动或运动复杂性有氧运动作为药物治疗附加干预,每周2次、每次60分钟、共24周。
- 运动强度维持在自觉用力程度量表12-14分(约最大心率的70-80%)。
- 主要结局为蒙哥马利-阿斯伯格抑郁评定量表评分变化,评估者设盲。
核心结论
- 该试验将比较连续有氧运动与运动复杂性有氧运动对抑郁症患者抑郁评分、认知功能、海马体积等的影响。
- 据作者所知,这是首个在药物治疗基础上添加运动复杂性有氧运动并评估抑郁症状和医疗费用变化的实用性试验。
研究设计与样本
- 患者按抑郁评分和抑郁发作次数平衡后随机分为不运动对照组、连续有氧运动组和运动复杂性有氧运动组。
- 干预组每周运动2次(非连续日)、每次60分钟,共24周;设盲评估者在干预前后评估患者。
关键数值与推荐
- 运动强度维持在自觉用力程度量表12-14分,约相当于最大心率的70-80%。
- 主要结局为蒙哥马利-阿斯伯格抑郁评定量表评分变化。
- 次要结局包括认知功能、海马体积、脑源性神经营养因子表达、睡眠参数、心血管风险参数、自杀行为、功能性和治疗费用。
临床怎么用
- 该方案为抑郁症药物治疗附加有氧运动(含运动复杂性)的临床实施提供随机对照试验证据基础。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with major depression disorder presents increased rates of cognitive decline, reduced hippocampal volume, poor sleep quality, hypertension, obesity, suicidal ideation and behavior, and decreased functionality. Although continuous aerobic exercise (CAE) improves some of the aforementioned symptoms, comorbidities, and conditions, recent studies have suggested that performing aerobic exercise with motor complexity (AEMC) may be more beneficial for cognitive decline, hippocampal volume, and functionality. Therefore, this randomized controlled trial will compare the effects of CAE and AEMC on depression score, cognitive function, hippocampal volume, brain-derived neurotrophic factor expression, sleep parameters, cardiovascular risk parameters, suicidal behavior, functionality, and treatment costs in patients with depression. METHODS/DESIGN: Seventy-five medicated patients with depression will be recruited from a Basic Healthcare Unit to participate in this prospective, parallel group, single blinded, superiority, randomized controlled trial. Patients with depression according to DSM-V criteria will be balanced and randomly assigned (based on depression scores and number of depressive episodes) to a non-exercising control (C), CAE, and AEMC groups. The CAE and AEMC groups will exercise for 60 min, twice a week for 24 weeks (on non-consecutive days). Exercise intensity will be maintained between 12 and 14 points of the rating of perceived exertion scale (~ 70-80% of the maximum heart rate). The CAE group will perform a continuous aerobic exercise while the AEMC group will perform exercises with progressively increased motor complexity. Blinded raters will assess patients before and after the intervention period. The primary outcome measure will be the change in depression score measured by the Montgomery-Asberg Depression Rating Scale. Secondary outcomes will include measures of cognitive function, hippocampal volume, brain-derived neurotrophic factor expression, sleep parameters, cardiovascular risk parameters, suicidal behavior, functionality, and treatment costs. DISCUSSION: This study was selected in the call of public policy programs for the Brazilian Unified National Health System - "PPSUS 2015". To our knowledge, this is the first pragmatic trial to test the effect of adding AEMC to the pharmacological treatment of patients with depression and to evaluate the possible reductions in depression symptoms and healthcare costs. TRIAL REGISTRATION: Brazilian Clinical Trials Registry (ReBec) - RBR-9zgxzd - Registered on 4 Jan. 2017.
引用
- Neves LM, Silva-Batista C, Marquesini R, et al. Aerobic exercise program with or without motor complexity as an add-on to the pharmacological treatment of depression - study protocol for a randomized controlled trial. Trials. 2018. PMID: 30305151. doi:10.1186/s13063-018-2906-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。